BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2140236)

  • 1. Changes in hemostasis activity during delivery and the immediate postpartum period.
    Gerbasi FR; Bottoms S; Farag A; Mammen EF
    Am J Obstet Gynecol; 1990 May; 162(5):1158-63. PubMed ID: 2140236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intravascular coagulation associated with pregnancy.
    Gerbasi FR; Bottoms S; Farag A; Mammen E
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):385-9. PubMed ID: 2137574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy.
    Bellart J; Gilabert R; Miralles RM; Monasterio J; Cabero L
    Gynecol Obstet Invest; 1998; 46(1):17-21. PubMed ID: 9692335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serial hemostasis-related changes in patients with cerebral infarction: comparison between progressing and non-progressing stroke.
    Ho CH; Hu HH; Wong WJ
    Thromb Res; 1989 Dec; 56(5):635-47. PubMed ID: 2534001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of coagulation system in dilated cardiomyopathy: comparison of patients with and without left ventricular thrombus.
    Riza Erbay A; Turhan H; Aksoy Y; Senen K; Yetkin E
    Coron Artery Dis; 2004 Aug; 15(5):265-8. PubMed ID: 15238823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium.
    Beller FK; Ebert C
    Eur J Obstet Gynecol Reprod Biol; 1982 May; 13(3):177-97. PubMed ID: 6178627
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
    Nakajima H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
    Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
    N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated fibrin(ogen) degradation products in the adult respiratory distress syndrome.
    Haynes JB; Hyers TM; Giclas PC; Franks JJ; Petty TL
    Am Rev Respir Dis; 1980 Dec; 122(6):841-7. PubMed ID: 6450559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular marker for hemostasis and thrombosis].
    Fukutake K; Fujimaki M
    Nihon Rinsho; 1989 Apr; 47(4):883-90. PubMed ID: 2664266
    [No Abstract]   [Full Text] [Related]  

  • 15. Preeclampsia, delivery, and the hemostatic system.
    Saleh AA; Bottoms SF; Welch RA; Ali AM; Mariona FG; Mammen EF
    Am J Obstet Gynecol; 1987 Aug; 157(2):331-6. PubMed ID: 2441602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in fibrinogen, fibrin-fibrinogen degradation products and fibrinolytic activity during pregnancy, labor and the puerperium in pregnant women with chronic hypertension].
    Kendić S; Mujezinović O; Muratović H
    Med Arh; 2000; 54(1):29-31. PubMed ID: 10872273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer.
    Kang J; Kambayashi J; Sakon M; Tsujinaka T; Mori T
    Jpn J Surg; 1989 May; 19(3):262-8. PubMed ID: 2674499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrinolysis during and after normal childbirth.
    Mackinnon S; Walker ID; Davidson JF; Walker JJ
    Br J Haematol; 1987 Mar; 65(3):339-42. PubMed ID: 2436648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on coagulation-fibrinolysis during normal pregnancy, labor and puerperium using recently developed molecular markers].
    Komatsu Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):627-34. PubMed ID: 7636333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.